Martinelli-Boneschi F - Search Results

1

Association between DPP6 polymorphism and the risk of progressive multiple sclerosis in Northern and Southern Europeans.

Brambilla P, Esposito F, Lindstrom E, Sorosina M, Giacalone G, Clarelli F, Rodegher M, Colombo B, Moiola L, Ghezzi A, Capra R, Collimedaglia L, Coniglio G, Celius EG, Galimberti D, Sørensen PS, Martinelli V, Oturai AB, Harbo HF, Hillert J, Comi G, Martinelli-Boneschi F. Brambilla P, et al. Neurosci Lett. 2012 Nov 21;530(2):155-60. doi: 10.1016/j.neulet.2012.10.008. Epub 2012 Oct 13. Neurosci Lett. 2012. PMID: 23069673

2

Association study of a new polymorphism in the PECAM-1 gene in multiple sclerosis.

Sciacca FL, Ferri C, D'Alfonso S, Bolognesi E, Martinelli Boneschi F, Cuzzilla B, Colombo B, Comi G, Canal N, Grimaldi LM. Sciacca FL, et al. J Neuroimmunol. 2000 May 1;104(2):174-8. doi: 10.1016/s0165-5728(99)00274-x. J Neuroimmunol. 2000. PMID: 10713357

3

MRI and motor evoked potential findings in nondisabled multiple sclerosis patients with and without symptoms of fatigue.

Colombo B, Martinelli Boneschi F, Rossi P, Rovaris M, Maderna L, Filippi M, Comi G. Colombo B, et al. J Neurol. 2000 Jul;247(7):506-9. doi: 10.1007/s004150070148. J Neurol. 2000. PMID: 10993490

4

Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement--EEG evidence.

Leocani L, Colombo B, Magnani G, Martinelli-Boneschi F, Cursi M, Rossi P, Martinelli V, Comi G. Leocani L, et al. Neuroimage. 2001 Jun;13(6 Pt 1):1186-92. doi: 10.1006/nimg.2001.0759. Neuroimage. 2001. PMID: 11352624

5

Cerebral grey matter pathology and fatigue in patients with multiple sclerosis: a preliminary study.

Codella M, Rocca MA, Colombo B, Martinelli-Boneschi F, Comi G, Filippi M. Codella M, et al. J Neurol Sci. 2002 Feb 15;194(1):71-4. doi: 10.1016/s0022-510x(01)00682-7. J Neurol Sci. 2002. PMID: 11809169 Clinical Trial.

6

Effects of glatiramer acetate on relapse rate and accumulated disability in multiple sclerosis: meta-analysis of three double-blind, randomized, placebo-controlled clinical trials.

Martinelli Boneschi F, Rovaris M, Johnson KP, Miller A, Wolinsky JS, Ladkani D, Shifroni G, Comi G, Filippi M. Martinelli Boneschi F, et al. Mult Scler. 2003 Aug;9(4):349-55. doi: 10.1191/1352458503ms932oa. Mult Scler. 2003. PMID: 12926839

7

The use of magnetic resonance imaging in multiple sclerosis: lessons learned from clinical trials.

Martinelli Boneschi F, Rovaris M, Comi G, Filippi M. Martinelli Boneschi F, et al. Mult Scler. 2004 Aug;10(4):341-7. doi: 10.1191/1352458504ms1067rr. Mult Scler. 2004. PMID: 15327027 Review.

8

Evidence for use of glatiramer acetate in multiple sclerosis.

Comi G, Hartung HP, Martinelli Boneschi F. Comi G, et al. Lancet Neurol. 2005 Feb;4(2):75-6; discussion 76-7. doi: 10.1016/S1474-4422(05)00975-0. Lancet Neurol. 2005. PMID: 15664539 No abstract available.

9

Vascular endothelial growth factor gene variability is associated with increased risk for AD.

Del Bo R, Scarlato M, Ghezzi S, Martinelli Boneschi F, Fenoglio C, Galbiati S, Virgilio R, Galimberti D, Galimberti G, Crimi M, Ferrarese C, Scarpini E, Bresolin N, Comi GP. Del Bo R, et al. Ann Neurol. 2005 Mar;57(3):373-80. doi: 10.1002/ana.20390. Ann Neurol. 2005. PMID: 15732116

10

Immunological patterns identifying disease course and evolution in multiple sclerosis patients.

Furlan R, Rovaris M, Martinelli Boneschi F, Khademi M, Bergami A, Gironi M, Deleidi M, Agosta F, Franciotta D, Scarpini E, Uccelli A, Zaffaroni M, Kurne A, Comi G, Olsson T, Filippi M, Martino G. Furlan R, et al. J Neuroimmunol. 2005 Aug;165(1-2):192-200. doi: 10.1016/j.jneuroim.2005.04.012. J Neuroimmunol. 2005. PMID: 15949850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

189 results

Search Page

Filters